CLINICAL_TRIALS
trial_result
· 2011-04-14
Clinical Trial Update: A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder [Phase 2]
Summary
Phase 2 trial update evaluating the efficacy and tolerability of SSR125543 in outpatients with major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Major Depression | Phase 2 | Status: COMPLETED